Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection
View ORCID ProfileMarc Stegger, View ORCID ProfileSofie Marie Edslev, View ORCID ProfileRaphael Niklaus Sieber, Anna Cäcilia Ingham, View ORCID ProfileKim Lee Ng, View ORCID ProfileMan-Hung Eric Tang, View ORCID ProfileSoren Alexandersen, View ORCID ProfileJannik Fonager, Rebecca Legarth, Magdalena Utko, Bartlomiej Wilkowski, View ORCID ProfileVithiagaran Gunalan, View ORCID ProfileMarc Bennedbæk, View ORCID ProfileJonas Byberg-Grauholm, Camilla Holten Møller, View ORCID ProfileLasse Engbo Christiansen, View ORCID ProfileChristina Wiid Svarrer, View ORCID ProfileKirsten Ellegaard, View ORCID ProfileSharmin Baig, View ORCID ProfileThor Bech Johannesen, View ORCID ProfileLaura Espenhain, View ORCID ProfileRobert Skov, View ORCID ProfileArieh Sierra Cohen, View ORCID ProfileNicolai Balle Larsen, Karina Meden Sørensen, Emily Dibba White, View ORCID ProfileTroels Lillebaek, View ORCID ProfileHenrik Ullum, View ORCID ProfileTyra Grove Krause, View ORCID ProfileAnders Fomsgaard, View ORCID ProfileSteen Ethelberg, View ORCID ProfileMorten Rasmussen
doi: https://doi.org/10.1101/2022.02.19.22271112
Marc Stegger
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Sofie Marie Edslev
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Raphael Niklaus Sieber
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Anna Cäcilia Ingham
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Kim Lee Ng
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Man-Hung Eric Tang
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Soren Alexandersen
2Division of Diagnostic Preparedness, Statens Serum Institut, Copenhagen, Denmark
3School of Medicine, Deakin University, Geelong, Australia
Jannik Fonager
4Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark
Rebecca Legarth
5Division of Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark
Magdalena Utko
7Danish National Biobank, Statens Serum Institut, Copenhagen, Denmark
Bartlomiej Wilkowski
6TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark
7Danish National Biobank, Statens Serum Institut, Copenhagen, Denmark
Vithiagaran Gunalan
4Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark
Marc Bennedbæk
4Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark
Jonas Byberg-Grauholm
8Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark
Camilla Holten Møller
5Division of Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark
Lasse Engbo Christiansen
9Department of Applied Mathematics and Computer Science, Dynamical Systems, Technical University of Denmark, Kgs. Lyngby, Denmark
Christina Wiid Svarrer
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Kirsten Ellegaard
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Sharmin Baig
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Thor Bech Johannesen
1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
Laura Espenhain
5Division of Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark
Robert Skov
5Division of Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark
Arieh Sierra Cohen
6TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark
Nicolai Balle Larsen
6TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark
Karina Meden Sørensen
7Danish National Biobank, Statens Serum Institut, Copenhagen, Denmark
Emily Dibba White
5Division of Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark
Troels Lillebaek
10International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark
11Global Health Section, University of Copenhagen, Copenhagen, Denmark
Henrik Ullum
12Statens Serum Institut, Copenhagen, Denmark
Tyra Grove Krause
5Division of Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark
Anders Fomsgaard
4Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark
Steen Ethelberg
5Division of Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark
13Department of Public Health, Global Health Section, University of Copenhagen, Copenhagen, Denmark
Morten Rasmussen
4Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark
Data Availability
The data are available for research upon reasonable request to the Danish Health Data Authority and Statens Serum Institut and within the framework of the Danish data protection legislation and any required permission from authorities. Consensus genome data from the Danish cases are routinely shared publicly at GISAID (www.gisaid.org), including information on reinfections.
Posted February 22, 2022.
Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection
Marc Stegger, Sofie Marie Edslev, Raphael Niklaus Sieber, Anna Cäcilia Ingham, Kim Lee Ng, Man-Hung Eric Tang, Soren Alexandersen, Jannik Fonager, Rebecca Legarth, Magdalena Utko, Bartlomiej Wilkowski, Vithiagaran Gunalan, Marc Bennedbæk, Jonas Byberg-Grauholm, Camilla Holten Møller, Lasse Engbo Christiansen, Christina Wiid Svarrer, Kirsten Ellegaard, Sharmin Baig, Thor Bech Johannesen, Laura Espenhain, Robert Skov, Arieh Sierra Cohen, Nicolai Balle Larsen, Karina Meden Sørensen, Emily Dibba White, Troels Lillebaek, Henrik Ullum, Tyra Grove Krause, Anders Fomsgaard, Steen Ethelberg, Morten Rasmussen
medRxiv 2022.02.19.22271112; doi: https://doi.org/10.1101/2022.02.19.22271112
Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection
Marc Stegger, Sofie Marie Edslev, Raphael Niklaus Sieber, Anna Cäcilia Ingham, Kim Lee Ng, Man-Hung Eric Tang, Soren Alexandersen, Jannik Fonager, Rebecca Legarth, Magdalena Utko, Bartlomiej Wilkowski, Vithiagaran Gunalan, Marc Bennedbæk, Jonas Byberg-Grauholm, Camilla Holten Møller, Lasse Engbo Christiansen, Christina Wiid Svarrer, Kirsten Ellegaard, Sharmin Baig, Thor Bech Johannesen, Laura Espenhain, Robert Skov, Arieh Sierra Cohen, Nicolai Balle Larsen, Karina Meden Sørensen, Emily Dibba White, Troels Lillebaek, Henrik Ullum, Tyra Grove Krause, Anders Fomsgaard, Steen Ethelberg, Morten Rasmussen
medRxiv 2022.02.19.22271112; doi: https://doi.org/10.1101/2022.02.19.22271112
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)